Literature DB >> 2552819

Enhanced erythropoietin secretion in hepatoblastoma cells in response to hypoxia.

M Ueno1, I Seferynska, B Beckman, J Brookins, J Nakashima, J W Fisher.   

Abstract

Erythropoietin (Ep) levels in spent culture media of a Hep G2 human hepatoblastoma cell line were measured by radioimmunoassay (RIA), fetal mouse liver erythroid colony formation (FMLC), and the exhypoxic polycythemic mouse assay (EHPCMA). The Hep G2 cells at high density produced approximately 700 mU/ml Ep when measured with the RIA. On the other hand, the Ep levels when assayed in EHPCMA and FMLC were 50 and 2,600 mU/ml, respectively. The bioactivity in FMLC was completely neutralized by an antibody to purified human recombinant Ep, indicating that the erythropoietic activity in the Hep G2 spent culture medium was immunologically equivalent to Ep. Ep levels in the medium from low-density Hep G2 cells in 5% O2 and 1% O2 were 2.5- and 4-fold greater, respectively, than that of 20% O2. In contrast, hyperoxia (40% O2) significantly inhibited Ep production. A significant increase in Ep secretion was also observed when the cells were incubated with cobaltous chloride (2 X 10(-6) -2.5 X 10(-4) M). Tunicamycin (0.5 micrograms/ml), which inhibits N-linked glycosylation, significantly reduced the enhancement of Ep secretion induced by hypoxia (1% O2) without affecting cell growth. Forskolin and cholera toxin, each of which increased the levels of cyclic AMP in the Hep G2 cells by 40-fold, produced a significant (P less than 0.05) further increase in Ep secretion in the presence of hypoxia.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2552819     DOI: 10.1152/ajpcell.1989.257.4.C743

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Oxygen-dependent erythropoietin production by the isolated perfused rat kidney.

Authors:  H Scholz; H J Schurek; K U Eckardt; A Kurtz; C Bauer
Journal:  Pflugers Arch       Date:  1991-04       Impact factor: 3.657

Review 2.  Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.

Authors:  Sameer Doshi; Wojciech Krzyzanski; Susan Yue; Steven Elliott; Andrew Chow; Juan José Pérez-Ruixo
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

3.  Immunocytochemical demonstration of erythropoietin in hypoxic human hepatoma cultures.

Authors:  C Herkens; M Wolff; J Fandrey; F Schuler; W Jelkmann
Journal:  Histochemistry       Date:  1993-10

4.  Oxygen-dependent expression of the erythropoietin gene in rat hepatocytes in vitro.

Authors:  K U Eckardt; C W Pugh; P J Ratcliffe; A Kurtz
Journal:  Pflugers Arch       Date:  1993-06       Impact factor: 3.657

5.  Effects of chemotherapeutic and immunosuppressive drugs on the production of erythropoietin in human hepatoma cultures.

Authors:  M Wolff; W Jelkmann
Journal:  Ann Hematol       Date:  1993-01       Impact factor: 3.673

6.  Inhibitory effect of zinc on stimulated erythropoietin synthesis in HepG2 cells.

Authors:  J Dittmer; C Bauer
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

7.  Alteration of protein levels during influenza virus H1N1 infection in host cells: a proteomic survey of host and virus reveals differential dynamics.

Authors:  Susann Kummer; Max Flöttmann; Björn Schwanhäusser; Christian Sieben; Michael Veit; Matthias Selbach; Edda Klipp; Andreas Herrmann
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

Review 8.  Granulocyte colony-stimulating factor-producing hepatocellular carcinoma with abrupt changes.

Authors:  Hiroaki Nagata; Shuhei Komatsu; Wataru Takaki; Tokunari Okayama; Yasunori Sawabe; Michiaki Ishii; Mitsuo Kishimoto; Eigo Otsuji; Hiroshi Konosu
Journal:  World J Clin Oncol       Date:  2016-10-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.